Cumberland Pharmaceuticals (CPIX) Competitors

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Omeros (NASDAQ:OMER) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.

Which has more volatility and risk, CPIX or OMER?

Cumberland Pharmaceuticals has a beta of -0.35, meaning that its share price is 135% less volatile than the S&P 500. Comparatively, Omeros has a beta of 2.42, meaning that its share price is 142% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in CPIX or OMER?

15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. Comparatively, 48.8% of Omeros shares are held by institutional investors. 44.8% of Cumberland Pharmaceuticals shares are held by company insiders. Comparatively, 12.3% of Omeros shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media prefer CPIX or OMER?

In the previous week, Omeros had 18 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 18 mentions for Omeros and 0 mentions for Cumberland Pharmaceuticals. Cumberland Pharmaceuticals' average media sentiment score of 0.54 beat Omeros' score of -0.10 indicating that Cumberland Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Cumberland Pharmaceuticals	Positive
Omeros	Neutral

Does the MarketBeat Community believe in CPIX or OMER?

Omeros received 562 more outperform votes than Cumberland Pharmaceuticals when rated by MarketBeat users. Likewise, 70.65% of users gave Omeros an outperform vote while only 41.81% of users gave Cumberland Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Cumberland Pharmaceuticals	Outperform Votes 189 41.81%	Underperform Votes 263 58.19%
Omeros	Outperform Votes 751 70.65%	Underperform Votes 312 29.35%

Is CPIX or OMER more profitable?

Omeros has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -29.54%. Omeros' return on equity of 0.00% beat Cumberland Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cumberland Pharmaceuticals	-29.54%	-9.50%	-3.19%
Omeros	N/A	N/A	-49.92%

Do analysts rate CPIX or OMER?

Omeros has a consensus price target of $22.50, indicating a potential upside of 583.89%. Given Omeros' stronger consensus rating and higher probable upside, analysts plainly believe Omeros is more favorable than Cumberland Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cumberland Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Omeros	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80

Which has stronger valuation & earnings, CPIX or OMER?

Cumberland Pharmaceuticals has higher revenue and earnings than Omeros. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Omeros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cumberland Pharmaceuticals	$41.08M	1.83	-$6.28M	-$0.25	-20.12
Omeros	N/A	N/A	-$117.81M	-$2.65	-1.24

Summary

Omeros beats Cumberland Pharmaceuticals on 12 of the 18 factors compared between the two stocks.